Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 3 4 5 Next >
DUSA Pharmaceuticals to Present at the 4th Annual Maxim Group Growth Conference
November 11, 2010
from PR Newswire
DUSA Pharmaceuticals Reports Third Quarter 2010 Corporate Highlights and Financial Results
November 05, 2010
Company Records Significant Bottom Line Improvement; Quarterly Domestic Kerastick ® Revenues Increase 15% Read More
from PR Newswire
DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
November 02, 2010
from PR Newswire
DUSA Pharmaceuticals Named to Deloitte's 2010 Technology Fast 500 List of Fastest Growing Companies in North America
October 26, 2010
Third Consecutive Year DUSA Has Been Recognized Read More
from PR Newswire
DUSA Pharmaceuticals to Present at the Rodman & Renshaw 12th Annual Healthcare Conference
September 07, 2010
from PR Newswire
DUSA Pharmaceuticals Receives Response From FDA on Orphan Drug Designation Status
August 06, 2010
from PR Newswire
DUSA Pharmaceuticals Reports Second Quarter 2010 Corporate Highlights and Financial Results
August 03, 2010
Domestic Kerastick® revenues up 35% year over year; Company generates Q2 profits Read More
from PR Newswire
DUSA Pharmaceuticals, Inc.® to Host Second Quarter 2010 Corporate Highlights and Financial Results Conference Call
July 29, 2010
from PR Newswire
DUSA Pharmaceuticals Reports U.S. Patent Office Upholds Key Photodynamic Therapy Patent
June 24, 2010
from PR Newswire
DUSA Pharmaceuticals Announces Slate of Nominees for Election to the Board of Directors
May 13, 2010
New nominees include Paul Hondros, Alfred Altomari and David Wurzer Read More
from PR Newswire
DUSA Pharmaceuticals Reports First Quarter 2010 Corporate Highlights and Financial Results
May 11, 2010
Q1 Domestic Kerastick(R) Revenues up 33% year over year; Domestic PDT Revenues up 27% Read More
from PR Newswire
DUSA Pharmaceuticals Reports Notice of Allowance for Key PDT Device Patent
May 07, 2010
New patent will cover Levulan® PDT therapy until 2019 Read More
from PR Newswire
DUSA Pharmaceuticals, Inc.(R) to Host First Quarter 2010 Corporate Highlights and Financial Results Conference Call
May 06, 2010
from PR Newswire
DUSA Partners with The Skin Cancer Foundation to Provide Free Skin Cancer Screenings in City Near You
May 04, 2010
from PR Newswire
DUSA Pharmaceuticals to Present at Roth Capital Partners 22nd Annual OC Growth Stock Conference
March 09, 2010
from PR Newswire
DUSA Unveils Ergonomic Enhancements to BLU-U(R) at the American Academy of Dermatology Annual Meeting
March 05, 2010
BLU-U® Mobility Optimized for Health Care Professional Use Read More
from PR Newswire
DUSA Pharmaceuticals Reports Full Year 2009 Corporate Highlights and Financial Results
March 03, 2010
Company Reaches Profitability and Generates $1.6 Million in Positive Cash Flow in Q4 Read More
from Marketwired News Releases
DUSA Pharmaceuticals Reports Full Year 2009 Corporate Highlights and Financial Results
March 03, 2010
Company reaches profitability and generates $1.6 million in positive cash flow in Q4 Read More
from Business Wire News Releases
DUSA Pharmaceuticals Reports Full Year 2009 Corporate Highlights and Financial Results
March 03, 2010
Company reaches profitability and generates $1.6 million in positive cash flow in Q4 Read More
from PR Newswire
DUSA Pharmaceuticals, Inc.(R) to Host Fourth Quarter and Full Year 2009 Financial Results and Corporate Highlights Conference Call
February 26, 2010
from PR Newswire
DUSA Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
February 02, 2010
from PR Newswire
DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009
November 06, 2009
from PR Newswire
DUSA Pharmaceuticals Reports Third Quarter 2009 Corporate Highlights and Financial Results
November 06, 2009
from PR Newswire
DUSA Pharmaceuticals, Inc.(R) Announces Third Quarter Financial Results and Corporate Highlights Conference Call
November 03, 2009
from PR Newswire
DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units
October 28, 2009
from PR Newswire
DUSA Pharmaceuticals Named to Deloitte's 2009 Technology Fast 500 List of Fastest Growing Companies in North America
October 21, 2009
from PR Newswire
DUSA Pharmaceuticals to Present at the Maxim Group 3rd Annual Growth Conference
September 22, 2009
from PR Newswire
DUSA Pharmaceuticals to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
September 02, 2009
from PR Newswire
DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results
August 11, 2009
from PR Newswire
DUSA Pharmaceuticals, Inc.(R) Announces Second Quarter Financial Results and Corporate Highlights Conference Call
August 06, 2009
from PR Newswire
< Previous 1 2 3 4 5 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here